|
| Exchange Disseminated Time | Caplin Point Laboratories Ltd has informed BSE that the Company’s state of art injectable Plant near Gummidipoondi, Tamil Nadu to cater regulated markets USA, EU, Brazil, South Africa etc., has commenced its commercial Production on March 27, 2014. This will now enable export of these products to Semi regulated and non regulated markets.
The Company has now initiated the process of submitting required documents for obtaining approval from regulatory bodies such as UKMHRA, ANVISA, BRAZIL, USFDA, EUGMP which would enable export of Injectables in various dosage forms to the regulated markets besides offering contract manufacturing for export to these markets. |
|
|